Jefferies Downgrades Big Pharma - Presented by: The Aol. On Network

This morning, Jefferies downgraded shares of Merck (MRK) from buy to hold after determining that the company's cost cutting efforts are less impressive than the market believes. With the downgrade, Jefferies lowered its EPS estimates and set a $50 price target.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.88 0.25 ▼ 1.38%
MU $ 18.51 1.39 ▼ 6.98%
FB $ 94.01 1.20 ▼ 1.26%
AAPL $ 121.30 1.07 ▼ 0.87%
SUNE $ 23.28 2.35 ▼ 9.17%
SUSQ $ 14.20 0.11 ▼ 0.77%
F $ 14.83 0.27 ▼ 1.79%
MSFT $ 46.70 0.18 ▼ 0.38%

As of 7/31/2015, 04:15 PM